- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06937489
The Effect of the Changes in Cylinder Power and Axis of Toric Soft Contact Lenses on the Visual Quality, Satisfaction and Vision Acceptability in Astigmatic Subjects
Toric SCL combined spheric lens power with cylinder power and axis. However, in Indonesia, the availability of cylinder power and axis parameter variations between products are still narrow, with stock-keeping units (SKUs) options only between 0.75-2.75 DC and 10o-180o for power and axis, respectively. Providing accurate toric SCL prescription for astigmatism patient in Indonesia remains a challenge for ophthalmologists and generally could not be achieved. Therefore, the aim of this study is to investigate the effect of power undercorrection and axis misalignment on visual acuity, contrast sensitivity, visual clarity, visual satisfaction, and vision acceptability.
The inclusion criteria for the trial, include: (1) 20 to 40 years of age without the need for presbyopic correction, (2) mild to moderate myopia patients, sphere between -1.00 and - 6.00 D combined with cylinder between -0.75 to -3.00 DC in at least one eye, (3) corrected distance visual acuity (VA) of with Toric SCL 6/15 or better bilaterally. Exclusion criteria include: (1) a history of contact lens use 6 months prior to trial, (2) history of previous ocular surgery, (3) anterior and posterior segment abnormalities, (4) manifest strabismus or dry eye, and (5) ocular and systemic diseases that would preclude CL wear or decrease visual acuity; and pregnancy or lactation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Detailed Procedure
Baseline refraction and clinical manifestations were determined during initial visit which each participants attended three assessment visits on a separate day. Baseline visual acuity was measured using Snellen chart, contrast sensitivity was measured using Pelli-Robson chart, and VAS (Visual Analog Scale, with 10 being the best indicator) was utilized to measure monocular clarity (1=blurred, 10=clear), satisfaction (1=satisfied, 10=unsatisfied), and vision acceptability (1=unacceptable, 10=perfectly acceptable).
Participants were fitted on their diseased eye, which could be unilateral or bilateral, with the toric SCL. Lens fit (corneal coverage, centration, movement, and rotation) was examined using slit-lamp examination. Regarding lens rotation, modification of the toric SCL axis was determined using the "LARS" (left add, right subtract) method for proper contact lens fitting. The shifting axis in toric SCL was assessed by observing the shift marker on contact lens in a clockwise or anticlockwise direction; then if any, it was corrected using LARS formula. A disposable toric lens investigated in this work is 2-Weeks Acuvue Moist for Astigmatism (2WAMfA), a common hydrogel conventional toric lenses.
The assessment visits interval is 1 week and completed exactly on day 14 after their first baseline visit. At each assessment visit, three different cylinder power were tested: 1) full cylinder power, 2) under-correction of cylinder power by 0.5 D, and 3) under-correction of cylinder power by 1.0 DC. Axis was also misaligned by -10° and +10° for each cylinder power alteration. The powers and axis assigned to the participants were randomized during every assessment visit. Baseline assessments and treatment allocations were masked to both patients and physician. All assessments were carried out on the day of observation and recorded on the subject evaluation sheet in accordance with the sample data, in which examinations results.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
DKI Jakarta
-
Jakarta, DKI Jakarta, Indonesia, 10430
- Department of Ophthalmology, Faculty of Medicine Universitas Indonesia Cipto Mangunkusumo Hospital, Indonesia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 20 to 40 years of age without the need for presbyopic correction
- mild to moderate myopia patients, sphere between -1.00 and - 6.00 D combined with cylinder between -0.75 to -3.00 DC in at least one eye
- corrected distance visual acuity (VA) of with Toric SCL 6/15 or better bilaterally.
Exclusion Criteria:
- a history of contact lens use 6 months prior to trial
- history of previous ocular surgery
- anterior and posterior segment abnormalities
- manifest strabismus or dry eye
- ocular and systemic diseases that would preclude CL wear or decrease visual acuity; and pregnancy or lactation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Undercorrection of toric soft contact lens
A disposable toric lens investigated in this work is 2-Weeks Acuvue Moist for Astigmatism (2WAMfA), a common hydrogel conventional toric lenses.
|
The assessment visits interval is 1 week and completed exactly on day 14 after their first baseline visit.
At each assessment visit, three different cylinder power were tested: 1) full cylinder power, 2) under-correction of cylinder power by 0.5 D, and 3) under-correction of cylinder power by 1.0 DC.
Axis was also misaligned by -10° and +10° for each cylinder power alteration.
The powers and axis assigned to the participants were randomized during every assessment visit.
Baseline assessments and treatment allocations were masked to both patients and physician.
All assessments were carried out on the day of observation and recorded on the subject evaluation sheet in accordance with the sample data, in which examinations results.
The assessment visits interval is 1 week and completed exactly on day 14 after their first baseline visit.
At each assessment visit, three different cylinder power were tested: 1) full cylinder power, 2) under-correction of cylinder power by 0.5 D, and 3) under-correction of cylinder power by 1.0 DC.
Axis was also misaligned by -10° and +10° for each cylinder power alteration.
The powers and axis assigned to the participants were randomized during every assessment visit.
Baseline assessments and treatment allocations were masked to both patients and physician.
All assessments were carried out on the day of observation and recorded on the subject evaluation sheet in accordance with the sample data, in which examinations results.
|
|
Active Comparator: Axis misalignment of toric soft contact lens
A disposable toric lens investigated in this work is 2-Weeks Acuvue Moist for Astigmatism (2WAMfA), a common hydrogel conventional toric lenses.
|
The assessment visits interval is 1 week and completed exactly on day 14 after their first baseline visit.
At each assessment visit, three different cylinder power were tested: 1) full cylinder power, 2) under-correction of cylinder power by 0.5 D, and 3) under-correction of cylinder power by 1.0 DC.
Axis was also misaligned by -10° and +10° for each cylinder power alteration.
The powers and axis assigned to the participants were randomized during every assessment visit.
Baseline assessments and treatment allocations were masked to both patients and physician.
All assessments were carried out on the day of observation and recorded on the subject evaluation sheet in accordance with the sample data, in which examinations results.
The assessment visits interval is 1 week and completed exactly on day 14 after their first baseline visit.
At each assessment visit, three different cylinder power were tested: 1) full cylinder power, 2) under-correction of cylinder power by 0.5 D, and 3) under-correction of cylinder power by 1.0 DC.
Axis was also misaligned by -10° and +10° for each cylinder power alteration.
The powers and axis assigned to the participants were randomized during every assessment visit.
Baseline assessments and treatment allocations were masked to both patients and physician.
All assessments were carried out on the day of observation and recorded on the subject evaluation sheet in accordance with the sample data, in which examinations results.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual acuity
Time Frame: Week 1 and week 2
|
Visual acuity was measured using Snellen chart and reported with logMAR
|
Week 1 and week 2
|
|
Contrast sensitivity was measured using Pelli-Robson chart,
Time Frame: Week 1 and week 2
|
Contrast sensitivity was measured using Pelli-Robson chart,
|
Week 1 and week 2
|
|
Monocular clarity
Time Frame: Week 1 and week 2
|
VAS (Visual Analog Scale, with 10 being the best indicator) was utilized to measure monocular clarity (1=blurred, 10=clear)
|
Week 1 and week 2
|
|
Visual satisfaction
Time Frame: Week 1 and week 2
|
VAS (Visual Analog Scale, with 10 being the best indicator) was utilized to measure visual satisfaction (1=satisfied, 10=unsatisfied)
|
Week 1 and week 2
|
|
Vision acceptability
Time Frame: Week 1 and week 2
|
VAS (Visual Analog Scale, with 10 being the best indicator) was utilized to measure vision acceptability (1=unacceptable, 10=perfectly acceptable).
|
Week 1 and week 2
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tri Rahayu, MD, Department of Ophthalmology, Faculty of Medicine Universitas Indonesia Cipto Mangunkusumo Hospital, Indonesia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20-07-0813
- PUTI Saintekes 2020 Grant (Other Identifier: Universitas Indonesia)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
London Vision ClinicOptana GmbHActive, not recruitingCorneal AstigmatismUnited Kingdom
-
Eye Hospital Pristina KosovoActive, not recruiting
-
Yonsei UniversityUnknownMyopic AstigmatismKorea, Republic of
-
Abbott Medical OpticsCompletedRefractive AstigmatismAustria
-
Ohio State UniversityAlcon ResearchCompletedAstigmatism BilateralUnited States
-
Ohio State UniversityCompletedAstigmatism BilateralUnited States
-
CooperVision, Inc.Completed
-
Cairo UniversityUnknown
Clinical Trials on Hydrogel conventional toric lenses with undercorrection of 0.5 D
-
PD Dr. med. Eckart BertelmannCompleted
-
Charite University, Berlin, GermanyCompleted
-
PD Dr. med. Eckart BertelmannCompleted
-
Tomsk National Research Medical Center of the Russian...RecruitingHeart Failure | Left Bundle-Branch Block | Ischemic Cardiomyopathy | Left Ventricular Dysfunction | Non-ischemic Dilated Cardiomyopathy | Left Ventricle RemodelingRussian Federation
-
Vectura LimitedCompleted
-
Jessa HospitalCompletedAnesthesia, Local | SurgeryBelgium
-
Agricultural University of AthensCompletedHypertension | Dyslipidemias | Overweight and Obesity | PrediabetesGreece
-
Imperial Brands PLCCompletedHealthy VolunteersUnited Kingdom
-
Instituto de Investigación Sanitaria AragónHospital Clínico Universitario Lozano Blesa; Cooperativas Lacteas UnidasRecruiting
-
IGLESIAS Juan FernandoUniversity of BernRecruiting